Equities

cbdMD Inc

cbdMD Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.66
  • Today's Change-0.003 / -0.38%
  • Shares traded64.02k
  • 1 Year change-60.95%
  • Beta2.0217
Data delayed at least 15 minutes, as of Jun 07 2024 21:10 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

cbdMD, Inc. produces and distributes cannabidiol (CBD) products. The Company owns and operates CBD brands cbdMD, Paw CBD and cbdMD Botanicals. Its cbdMD brand of products includes a range of premium every day and functional CBD products, including tinctures; gummies; topicals; capsules; drink mixes; and sleep, focus and calming aids.Its Paw CBD brand of products includes a line of veterinarian-formulated products including tinctures, chews, topicals products in varying strengths and formulas. Its cbdMD Botanicals brand of beauty and skincare products features facial oil and serum, toners, moisturizers, clear skin, facial masks, exfoliants and body care stock-keeping units (SKU). cbdMD, Paw CBD and cbdMD Botanicals products are distributed through its e-commerce websites, third party ecommerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers. Its products are sold through www.cbdmd.com, www.pawcbd.com, and cbdmdbotanicals.com Websites.

  • Revenue in USD (TTM)21.58m
  • Net income in USD-25.65m
  • Incorporated2015
  • Employees52.00
  • Location
    cbdMD Inc8845 Red Oak BlvdCHARLOTTE 28217-5593United StatesUSA
  • Phone+1 (704) 445-3060
  • Websitehttps://www.cbdmd.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Finch Therapeutics Group Inc0.00-16.28m2.30m18.00--0.1209-----10.14-10.140.0011.860.00-------25.22---28.97--------------0.00---87.57--34.80------
Axim Biotechnologies Inc85.35k-5.59m2.31m6.00------27.05-0.0249-0.02490.0003-0.02680.0214----14,225.00-140.13-154.34---390.73-----6,548.75-36,362.71---1.16----345.05-27.38-29.10------
Eloxx Pharmaceuticals Inc0.00-20.48m2.31m18.00---------9.06-9.060.00-6.530.00----0.00-124.43-115.27---155.33-----------16.69--------45.95---22.56--
Aclarion Inc60.05k-6.13m2.41m6.00--0.838--40.10-7.41-7.410.03410.35020.0215--3.5010,008.33-219.26---337.53---29.49---10,203.20------0.211--24.75--34.38------
Veritas Farms Inc730.65k-6.15m2.46m17.00--12.14--3.36-0.1319-0.13190.01360.00130.08770.80647.8042,979.41-69.02-72.11-123.21-93.59-220.0924.07-787.27-177.790.1392-5.560.95---63.42-0.942723.68---52.93--
Agile Therapeutics Inc21.50m-7.79m2.49m19.00------0.1156-3.65-3.656.98-1.511.632.905.421,131,316.00-59.25-94.24---142.6259.73---36.26-513.500.3843------80.02--43.08------
PaxMedica Inc0.00-18.15m2.50m6.00--2.01-----11.19-11.190.000.15940.00----0.00-474.77-755.77-781.78-------------3,015.030.00-------23.56------
InMed Pharmaceuticals Inc5.63m-6.08m2.51m13.00--0.1717--0.4464-1.23-1.230.92841.750.40062.7129.77---43.26-88.10-50.03-104.1939.20---108.01-1,066.115.80--0.00--279.60--57.27--29.56--
Virax Biolabs Group Ltd0.00-1.71m2.53m5.00---------1.50-1.500.00-0.8568------0.00----------------0.0223-112.29-----100.00---162.50------
Qrons Inc0.00-763.52k2.53m2.00---------0.0562-0.05620.00-0.10780.00----0.00-18,782.78-1,513.45---------------19.02---------7.61------
cbdMD Inc21.58m-25.65m2.55m52.00--0.6522--0.1183-19.96-19.969.271.010.89492.0921.27415,039.60-89.78-38.59-118.26-41.5062.7063.80-100.33-87.980.6107-3.010.4668---31.77120.9163.64---4.95--
CYANOTECH CORP22.49m-4.62m2.60m86.00--0.1867--0.1157-0.7265-0.72653.532.010.78891.5310.73261,546.50-16.19-2.32-21.07-2.9629.5935.88-20.52-2.330.3702-5.930.3299---35.56-7.44-259.70--1.22--
Sentient Brands Holdings Inc0.00-818.63k2.65m2.00---------0.0145-0.01450.00-0.0360.000.0188--0.00-317.87-220.36------41.81---31,451.190.0354-2.27-----73.68--34.98------
AgriFORCE Growing Systems Ltd16.28k-13.34m2.74m7.00--0.2654--168.09-10.78-10.780.00390.3960.0009--0.4432,325.71-74.39-78.95-100.77-109.8616.58---81,946.25-243,182.500.8186-1.300.1913------8.85--48.61--
Novelstem International Corp15.00k-4.22m2.82m15.00------187.84-0.09-0.090.0003-0.04780.0065--10.00---172.16---1,011.77-------26,418.53-----8.402.34--0.00---446.84------
Aridis Pharmaceuticals Inc22.36m-1.14m2.83m37.00------0.1264-0.1845-0.18450.7074-0.26482.40--58.45604,297.30-12.24-120.16---678.29-----5.11-1,559.63--------101.3729.1634.43---34.84--
Data as of Jun 07 2024. Currency figures normalised to cbdMD Inc's reporting currency: US Dollar USD

Institutional shareholders

3.56%Per cent of shares held by top holders
HolderShares% Held
Renaissance Technologies LLCas of 31 Mar 202436.01k1.18%
Virtu Americas LLCas of 31 Mar 202419.94k0.66%
UBS Securities LLCas of 31 Mar 202414.54k0.48%
The Vanguard Group, Inc.as of 31 Mar 202413.04k0.43%
BlackRock Fund Advisorsas of 31 Mar 202411.66k0.38%
Geode Capital Management LLCas of 31 Mar 202411.52k0.38%
RBC Dominion Securities, Inc.as of 31 Mar 2024725.000.02%
Merrill Lynch, Pierce, Fenner & Smith, Inc. (Invt Mgmt)as of 31 Mar 2024489.000.02%
Qube Research & Technologies Ltd.as of 31 Mar 2024300.000.01%
Harbour Investments, Inc.as of 31 Dec 2023159.000.01%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.